Improved plasma lipids, anti-inflammatory activity, and microbiome shifts in overweight participants: two clinical studies on oral supplementation with algal sulfated polysaccharide

HIGHLIGHTS

• who: Lauren A. Roach and collaborators from the Health Sciences, University of Wollongong, Wollongong, NSW, Australia have published the paper: Improved Plasma Lipids, Anti-Inflammatory Activity, and Microbiome Shifts in Overweight Participants: Two Clinical Studies on Oral Supplementation with Algal Sulfated Polysaccharide, in the Journal: (JOURNAL)
• what: In the studies described here, the authors sought to understand how the gut microbiome is affected by ingesting a type of ulvan from the green seaweed Ulva sp. The aim was to confirm the Study 1 findings that SXRG84 would reduce non-HDL cholesterol in overweight participants. A . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.